General MedicationsORALStandard

PAROXETINE HYDROCHLORIDE

Standard Dose

EQ 10MG BASE/5ML

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview PAROXETINE HYDROCHLORIDE is listed in Drugs@FDA under application 219954 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PAROXETINE HYDROCHLORIDE Form and strength SUSPENSION;ORAL - EQ 10MG BASE/5ML Sponsor ANNORA PHARMA Submission history Latest submission status date: 2026-03-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview PAROXETINE HYDROCHLORIDE is listed in Drugs@FDA under application 219954 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PAROXETINE HYDROCHLORIDE Form and strength SUSPENSION;ORAL - EQ 10MG BASE/5ML Sponsor ANNORA PHARMA Submission history Latest submission status date: 2026-03-05 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.